Skip to main content
Shivalik Rasayan Ltd. logo

Shivalik Rasayan Ltd. — Investor Relations & Filings

Ticker · SHIVALIK ISIN · INE788J01021 LEI · 335800FEB4CFANKSV783 BSE.NS Manufacturing
Open in API
Filings indexed 226 across all filing types
Latest filing 2024-03-07 Regulatory Filings
Country IN India
Listing BSE.NS SHIVALIK

About Shivalik Rasayan Ltd.

https://shivalikrasayan.com/

Shivalik Rasayan Ltd. is a diversified chemical and pharmaceutical manufacturer specializing in the production of organophosphorus-based agrochemicals and high-potency active pharmaceutical ingredients (APIs). The company operates through two primary business segments: Agrochemicals and Pharmaceuticals. In the agrochemical sector, it is a leading producer of technical-grade insecticides, including Dimethoate and Malathion. Its pharmaceutical division focuses on the development and manufacture of oncology APIs and finished dosage forms, utilizing advanced research and development capabilities to serve global markets. Shivalik Rasayan maintains state-of-the-art manufacturing facilities designed to meet international regulatory standards, positioning itself as a key supplier of specialized chemical intermediates and complex therapeutic solutions for the healthcare and agricultural industries.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 07.03.2024 from Shivalik Rasayan Limited addressed to stock exchanges (BSE and NSE). It discloses that all required licenses for starting manufacturing at a newly built Agro-Chemical Plant have been received, trial batches have been successfully taken, and commercial production will start from April 2024. The document is brief (1705 characters), contains no financial data or detailed report content, and serves as an informational update to the exchanges and public. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any detailed financial or governance report. It is a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements, 2015, which is typical for Regulatory Filings (RNS). Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-03-07 English
Copy of Newspaper Publication
Regulatory Filings
2024-02-13 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a statement submitted under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically reporting on deviations or variations in the utilization of funds raised through a preferential issue for the quarter ended December 31, 2023. It includes details about the amount raised, intended use of funds, and confirms no deviation or variation in fund utilization. This type of filing is a regulatory compliance disclosure related to capital raising and fund utilization, not a full financial report or earnings release. It is not an announcement of a report publication but a regulatory filing itself. Therefore, the document fits best under the category of Regulatory Filings (RNS). The document length is 4475 characters, which is relatively short but contains substantive regulatory disclosure rather than just an announcement or certification.
2024-02-12 English
Financial Result Updates
Regulatory Filings
2024-02-12 English
Outcome of Board Meeting
Regulatory Filings
2024-02-12 English
Board Meeting — SHIVALIK RASAYAN LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for…
Regulatory Filings
2024-02-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.